N/A N=12 Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients
Stroke
Primary: Force Symmetry Ratio During Gait — 0.71; 0.83 ratio
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=44 Novel Methods for Ascertainment of Gout Flares -A Pilot Study
Gout
Primary: Preference IVR vs RheumPRO — 3; 28 Participants
N/A N=61 MONITOR-OA: Using Wearable Activity Trackers to Improve Physical Activity in Knee Osteoarthritis
Knee Osteoarthritis · Joint Diseases
Primary: Time Spent in Moderate-to-Vigorous Physical Activity (MVPA) — 62.1; 65.3; 75.5; 50.0 Minutes per day
Phase 2 N=100 YCFM (Youth Correctional Facilities Males)
Chlamydial Infection
Primary: Proportion of Participants Experiencing Treatment Failure After Treatment With Azithromycin for Uncomplicated Chlamydia Trachomatis (CT) in Males With and Without…
N/A N=20 Effect of Alveolar Minute Ventilation on Respiratory Gas Heat Content
Ventilation Perfusion Mismatch
Primary: Airway Enthalpy — 32; 23 Joules/Minute
Phase 3 N=753 Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
Bacterial Conjunctivitis
Primary: Number of Participants With Clinical Resolution Among Who Received SHP640 or Placebo on Day 5 — 111; 0; 95 Participants — p=0.127
N/A N=30 Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography
Liver Fibrosis · Liver Diseases
Primary: Deviations From Suggested Guidelines- Any Effect on Agreement — 0.77; 0.75; 0.69; 0.86 correlation coefficient
N/A N=38 Investigation of Trunk Muscle Size and Function in Older Adults With Chronic Low Back Pain
Low Back Pain
Primary: Difference in Percent Change From Baseline in L4 Paraspinal Cross-Sectional Area Asymmetry at 6 Weeks Between Intervention Arms — 0; -17.6 % change — p=1.000
N/A N=101 The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression
Depression
Primary: Treatment Response — 28; 29 Participants
N/A N=14 Backpack Load and Spine Muscles Activity
Child
Primary: Muscle Activity as a Measure of Route Mean Square — 13.96; 10.70; 10.85; 9.28 milivolts
N/A N=151 Systemic Lupus Erythematous and Heart Conduction Disorders
Lupus Erythematosus, Systemic · Atrioventricular Block · Sudden Death
Primary: Presence of Conduction Disorders in Patients With SLE Regarding to Its Serologic Profile — 89.22; 91.41; 145.68; 146.72 msec
N/A N=32 Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Disorder With Hyperactivity (ADHD)
Primary: Change in Performance on Conners Adult ADHD Rating Scale - Self-Report: Long Version (ADHD Symptoms) — -4.4; -5.1 t-score
Phase 1 N=15 Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC
Non Small Cell Lung Cancer
Primary: Treatment-Emergent Adverse Events — 3; 12; 3; 11 Participants
Phase 1 N=45 MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
Solid Tumors · ER/PR Positive Breast Cancer · Triple Negative Breast Cancer
Primary: Pilot Phase: Tumour Levels of Irinotecan and SN-38 at Cycle 1 Day 4 — 4253; 38.1 nanograms per gram (ng/g)
N/A N=484 Parent eReferral to Tobacco Quitline
Secondhand Smoke
Primary: Number of Parent Smokers Who Enrolled in Quitline — 209; 245; 24; 5 Participants